GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals Dupixent
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
Trials & Approvals CRISPR
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Trials & Approvals Gene Therapy
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Trials & Approvals Depression
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
Trials & Approvals Nasal Spray
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
Trials & Approvals
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
Trials & Approvals Breast Cancer
Eli Lilly’s Early Breast Cancer Drug Gets FDA Nod but Faces Tricky Rollout
2021-10-14
Takeda Hits the Brakes on Narcolepsy Drug Trials
2021-10-07
Trials & Approvals Atopic Dermatitis
Kyowa Kirin, Amgen’s Atopic Dermatitis Drug Delivers Strong Results in Phase 2 Trial
2021-10-05
Trials & Approvals Rare Disease
FDA Greenlights First and Only Treatment for Cholestatic Pruritus with ALGS
2021-10-04
Trials & Approvals CAR T-cell Therapy
FDA Approves Kite’s CAR-T Therapy for Adult Leukemia
2021-10-04
Trials & Approvals Gene Therapy
Decreasing Earnings and COVID Delays Spell Trouble for AGCT
2021-09-26
Trials & Approvals PARP Inhibitor
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
Trials & Approvals FDA Approval
FDA Approves Incyte’s Jakafi for Chronic Graft-Versus-Host Disease
2021-09-23
1 2 3 … 25
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
GO PRIME
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
GO PRIME
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
The 8 Companies Propelling Taiwan’s Biopharma Industry
2021-10-21
GO PRIME
READ MORE
EVENT
2021-10-27
Thailand LAB INTERNATIONAL 2021
Online
2021-10-27
BIOPLUS INTERPHEX KOREA 2021
Online
2021-10-28
Asia BioPharma Industry Innovation Summit 2021
Shanghai, China
2021-10-28
Medtech Connect: Beyond COVID – investigating and innovating for the next generation
Online
2021-10-25
AusBiotech 2021
Online and on-demand
2021-11-04
BIO Asia-Taiwan 2021
Taipei, Taiwan
SEE MORE
Newsletter
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2021 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top

Enjoy Your First 14 Days for $1.49

SUBSCRIBE NOW

Create an account with us now to say goodbye to all the pop-ups!